5AM Solutions Chooses IBM as Preferred Partner to Deliver On Demand Business Solutions for Health Care and Life Science Customers7 March 2006
5AM Solutions today announced it has achieved
industry optimized status in IBM's PartnerWorld Industry Networks. 5AM can
now take advantage of IBM's sales, marketing and technical expertise to
develop and deliver solutions that meet customer requirements in the health
care and life science industry.
Customers are seeking solutions that can help them better integrate
processes and applications and allow them to quickly respond to changing
market opportunities -- all key elements in transforming to an On Demand
business.
The opportunity was provided due to 5AM's expertise in building an
integrated solution with IBM software and hardware to achieve significant
customer results, particularly related to the enterprise solution provided
to the National Institutes of Health by way of the NIH Neuroscience
Microarray Consortium (http://arrayconsortium.tgen.org). Hosted by the
Translational Genomics Research Institute (TGen), the consortium is chaired
by Dr. Dietrich Stephan, Director of the Neurogenomics Division of TGen.
The division is the largest genotyping facility for Affymetrix chips with a
throughput of over 50,000 samples using the 10k, 100k and 500k SNP
platform. Called the Microarray Enterprise Manager (MEM), the solution
connects 4 sites (Duke, UCLA, Yale, and TGen) with over 10,000 extramural
scientists funded by 15 NIH institutes.
"With MEM, we need only a single coordinator to run the entire consortium.
The solution tracks work progress, houses data, and allows role-based and
HIPAA compliant views of the data," said Dr. Stephan.
5AM will use this status to work closer with IBM to capture customers,
create marketing campaigns, and advance application development on the IBM
platform. The two companies will continue to pursue a standards-based
approach to creating on-demand web solutions for the healthcare and life
science market. 5AM's expertise using Model Driven Architecture (MDA) to
create Service Oriented Architectures (SOA) has been accelerated using the
IBM Rational Software Development Suite and IBM WebSphere and DB2
platforms.
"We are excited about strengthening our relationship with IBM to grow our
business and strengthen our ability to serve customers in the life
sciences," said Brent Gendleman, CEO of 5AM.
"Access to open-standards based products on which to build cost effective
solutions is crucial to customers," said Buell Duncan, general manager, ISV
& Developer Relations, IBM. "We are pleased that 5AM Solutions has joined
PartnerWorld Industry Networks, committing to IBM as a partner of choice,
to deliver on demand business solutions to customers within the healthcare
and lifesciences industry."
The IBM PartnerWorld Industry Networks provide ISVs with comprehensive
business insight, technical resources, networking opportunities, and
marketing and sales support designed to help them reach more customers and
close deals faster. Participants in the PartnerWorld Industry Networks can
team with IBM to bring on demand solutions to market more easily and to
ensure these solutions meet specific industry needs, reflecting how
customers buy technology today.
ISVs can sign up for PartnerWorld Industry Networks at www.ibm.com/isv.
About 5AM Solutions
5AM Solutions is a software provider whose solutions and services target
life science companies who view data organization, work-flow optimization,
analysis, and global collaboration as key components of their success. Our
J2EE interoperable web solutions grant insight into the complex data
produced by the genomic revolution integrated with the directed collection
of clinical data across geography, discipline and IT disparities found
among collaborators around the globe or down the hall. An IBM Life Sciences
Optimized partner, we share a common passion with our clients to advance
medicine and science through our contribution of state-of-the-art software
development. www.5amsolutions.com
About TGen
TGen is a not-for-profit research institute whose primary mission is to
make and translate genomic discoveries into advances in human health.
Translational genomics research is a relatively new field employing
innovative advances arising from the Human Genome Project to apply to the
development of diagnostics, prognostics and therapies for cancer,
neurological disorders, diabetes and other complex diseases. www.tgen.org
Contact:
Brent Gendleman
602-722-1530 voice
1-888-577-8855 fax
Email Contact
SOURCE: 5AM Solutions
Source: marketwire
All trademarks and copyrighted information contained herein are the property of their respective owners.
Related Computer Hardware Articles
|
